Subject category:
Entrepreneurship
Published by:
London Business School
Abstract
This is the second of a two-case series. This case focuses on the European Marketing Board of Pharma, and the decision whether to approve expenditure on the UK's subsidiary's transdermal technology or not.
About
Abstract
This is the second of a two-case series. This case focuses on the European Marketing Board of Pharma, and the decision whether to approve expenditure on the UK's subsidiary's transdermal technology or not.